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Late Migration of Amplatzer Septal Occluder Device 
to the Descending Thoracic Aorta
Hyo-Hyun Kim, M.D., Gi-Jong Yi, M.D., Ph.D., Suk-Won Song, M.D., Ph.D.
Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine
Percutaneous closure of atrial septal defect (ASD) has become an increasingly common procedure. Serious 
complications of the procedure, such as cardiac migration, are rare, and usually occur ＜72 hours after de-
vice placement. In this report, we present the case of a patient who underwent successful surgical treatment 
for the migration of an ASD occluder device to the thoracic aorta 12 months after ASD closure.
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Atrial septal defect (ASD) is the fourth most com-
mon congenital heart defect, with an incidence of 
2.78 per 10,000 live births [1]. Surgical closure of 
ASD has been practiced for more than 45 years and 
is considered the method of choice. The first applica-
tion of ASD closure in humans was in 1974, by Lock 
[2], and the technique was pioneered by William. 
Recently, a variety of devices for transcatheter clo-
sure of ASD have become available, and this techni-
que is increasingly used as an alternative to open 
surgery [3,4]. The rate of failure, including dislodge-
ment, migration, or embolization, has been reported 
to be around 0.5% [5]. In this report, we present the 
case of a patient who underwent successful surgical 
treatment for the migration of an ASD occluder de-
vice to the descending aorta 12 months after ASD 
closure.
A 65-year-old man was admitted to the cardiology 
clinic at Gangnam Severance Hospital with pro-
gressively limiting exertional dyspnea. He had an 
ASD secundum, which had been diagnosed 10 years 
earlier. Echocardiography on admission showed a 
2.3×1.7-cm, oval-shaped ASD. The patient underwent 
transcatheter closure using a 24-mm Amplatzer sep-
tal occluder (AGA Medical Co., Golden Valley, MN, 
USA) guided by transesophageal echocardiography 
(TEE). Conventional chest radiography was per-
formed every morning after implantation. The patient 
was discharged after 3 days of hospitalization. The 
proper position of the device was confirmed by 
transthoracic echocardiography (TTE) on the day of 
discharge. There were no immediate postoperative 
complications.
The patient underwent clinical examination, elec-
trocardiography, chest radiography, and TTE at 1 
month and 6 months after ASD closure. At a routine 
follow-up visit, a year after implantation, the diag-
nosis of device migration was made based on a chest 
Korean J Thorac Cardiovasc Surg 2017;50:47-49 □ CASE REPORT □
https://doi.org/10.5090/kjtcs.2017.50.1.47
Hyo-Hyun Kim, et al
− 48 −
Fig. 1. (A, B) Chest computed to-
mography scan showing the mi-
grated Amplatzer occluder device.
Fig. 2. (A) Photograph taken during 
surgery showing the tear into the 
aorta caused by the edge of the 
Amplatzer device, and (B) an en 
face view of the device.
computed tomography (CT) scan and echocardiog-
raphy (Fig. 1). The chest CT scan showed the pres-
ence of the ASD occluder device in the descending 
thoracic aorta at the level of T6–T7. TEE showed no 
interruption in aortic blood flow between the device 
and the aortic lumen. The patient had no symptoms, 
such as chest discomfort or dyspnea, associated with 
ASD occluder migration. Physical examination re-
vealed no abnormal findings. Because of the risk of 
aortic plugging or perforation, the patient was re-
ferred to the operating room.
With the patient in the supine position, clamshell 
incisions were made bilaterally into the fifth inter-
costal space, and the pericardium was incised 
vertically. Following standard bicaval cannulation and 
aortic cross-clamping, antegrade blood cardioplegia 
was introduced. Patch repair of ASD was carried out 
using a bovine pericardial patch.
During the rewarming period, the descending 
thoracic aorta was cross-clamped at the level of T5 
(proximally) and T8 (distally), and was opened 
longitudinally. The device was removed through the 
incision after adhesiolysis (Fig. 2). The aortic wall 
was closed using a primary simple suture. Pathological 
examination of the retrieved specimen showed that 
structural integrity of the device was maintained 
without distortion (Fig. 2).
The aortic cross-clamp (ACC) time for the removal 
of the ASD device was 9 minutes, and the total oper-
ation time was 116 minutes with an ACC time of 43 
minutes. The patient stayed in the intensive care unit 
for 36 hours postoperatively. There were no peri-
operative or postoperative complications.
Discussion
Until recently, open surgical repair of ASD has 
been the only available treatment [1]. A number of 
different devices are available for transcatheter ASD 
closure, with the Amplatzer device being the first 
choice for closing defects of secundum ASD larger 
than 18 mm [4].
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The overall incidence of complications of trans-
catheter ASD closure has been reported to range 
from 6.1% to 11.1%, with embolization and malposi-
tion being the most common (3.5%), accounting for 
half of the complications during hospitalization. 
Embolization occurs with 24-mm or larger devices, 
while malposition occurs with 19-mm and 22-mm 
devices [1].
The dislocated device can migrate to the main pul-
monary artery [1,5], left ventricle, left atrium [6], as-
cending aorta [6], aortic arch [4], or descending 
thoracic aorta. Devices usually embolize into the 
main pulmonary artery (89%). Most migrations (67%) 
are detected within the first 24 hours [5], and migra-
tion to the descending thoracic aorta in the late post-
operative period (＞1 year) is an extremely rare 
occurrence. This case was remarkable for the fact 
that migration occurred a few months after im-
plantation, highlighting the need for careful fol-
low-up, particularly when the rim of the ASD is 
insufficient.
Divekar et al. [6] reviewed all the 29 reported 
complications of Amplatzer septal occluder devices 
and found that embolization tended to occur when 
the aortic rim was insufficient. In our case, it ap-
peared that the posterior rim of the atrial septum 
was very thin and highly mobile.
Classically, median sternotomy provides exposure 
to the anterior and middle mediastinum, and it is 
ideal for access to the heart and innominate vessels. 
However, the descending thoracic aorta and posterior 
aspect of the aortic arch are inaccessible through this 
approach. Bilateral anterior thoracotomies (clamshell) 
allow access to all aspects of the thoracic aorta, both 
pulmonary vessels, superior vena cava, inferior vena 
cava, both atria, and both ventricles [7]. Furthermore, 
this approach allows for easy extension to the neck 
and abdomen if further control is required [8]. 
Therefore, a clamshell incision was chosen for ASD 
device removal and ASD repair.
To the best of our knowledge, this is the first re-
ported case of the late migration of an occluder de-
vice to the descending thoracic aorta, and the only 
reported use of a clamshell incision for ASD device 
removal and ASD repair.
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